Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

DSIJ Intelligence Article rating: 3.6

The market opened in green on May 21, 2021, overall volumes in futures & options currently stand at 8,76,11,625 contracts with a turnover of Rs. 81,72,082.82 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

DSIJ Intelligence Article rating: 4.1

The market opened in green on May 21, 2021, overall volumes in futures & options currently stand at 8,76,11,625 contracts with a turnover of Rs. 81,72,082.82 crore.

Market news that you should not miss today
Market news that you should not miss today

Market news that you should not miss today

DSIJ Intelligence-3 Article rating: 4.1

Gufic Biosciences: The company has received permission from Central Drugs Standard Control Organisation, Ministry of Health & Family Welfare, New Delhi to manufacture & market Liposomal Amphotericin B injection 50 mg/vial (Lyophilised). The said injection is used to treat cases of Mucormycosis also called ‘Black Fungus’ that damages the nose, eyes, sinuses, and sometimes, even the brain.  

Unichem Laboratories soars over 7 per cent on getting nod for antidepressant tablets
Unichem Laboratories soars over 7 per cent on getting nod for antidepressant tablets

Unichem Laboratories soars over 7 per cent on getting nod for antidepressant tablets

DSIJ Intelligence Article rating: 5.0

Unichem Laboratories Limited today announced that it has received ANDA approval for its Amitriptyline HCI tablets from United States Food & Drug Administration (USFDA) to market a generic version of ELAVIL (Amitriptyline Hydrochloride) of AstraZeneca Pharmaceuticals LP.

RSS
First24932494249524962498250025012502Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR